{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-044711","form_type":"8-K","ticker":"GALT","cik":"0001133416","company_name":"GALECTIN THERAPEUTICS INC","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.865436+00:00","generated_at":"2026-05-16T13:55:24.169734+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Galectin Therapeutics shareholders elect all 11 directors, approve say-on-pay, set frequency at 3 years","bullets":["All 11 director nominees elected with >25M votes for each; highest was Benjamin S. Carson Sr. at 25.9M.","Advisory say-on-pay resolution approved: 25.3M for, 639k against, 310k abstain.","Shareholders chose a 3-year frequency for future say-on-pay votes (22.1M votes for 3 years).","Ratification of Cherry Bekaert LLP as independent auditor for FY2025 passed with 45.5M for, 142k against."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-044711","json":"https://secwatch.observer/filing/0001140361-25-044711.json","markdown":"https://secwatch.observer/filing/0001140361-25-044711.md","text":"https://secwatch.observer/filing/0001140361-25-044711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/0001140361-25-044711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125044711/ef20060738_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:55:24.169734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}